血清sTREM-1、NF-κB对脓毒症急性肺损伤患者疾病进展及预后的评估价值分析OA
Analysis of the Evaluation Value of Serum sTREM-1 and NF-κB in Disease Progression and Prognosis of Patients with Sepsis Acute Lung Injury
目的:探讨并分析血清可溶性髓样细胞触发受体-1(sTREM-1)、核转录因子-κB(NF-κB)对脓毒症急性肺损伤(ALI)患者疾病进展及预后的评估价值.方法:选取2022年3月—2024年3月在广西壮族自治区南溪山医院就诊的120例脓毒症ALI患者,依据疾病严重程度分为轻度组58例、中度组37例和重度组25例.比较患者sTREM-1、NF-κB水平、序贯性器官衰竭评分(SOFA)和急性生理与慢性健康状况评分Ⅱ(APACHE Ⅱ),应用Pearson相关分析探讨血清sTREM-1、NF-κB与SOFA及APACHEII评分的关联,对患者随访28d生存状况,利用受试者工作特征(ROC)曲线评估血清sTREM-1、NF-κB对脓毒症ALI的预测效能.结果脓毒症ALI患者血清sTREM-1、NF-κB水平以及SOFA和APACHE Ⅱ评分均:重度组>中度组>轻度组,差异有统计学意义(P<0.05);血清sTREM-1、NF-κB水平与SOFA及APACHEII评分呈正相关,差异有统计学意义(P<0.05);非生存组血清sTREM-1、NF-κB水平均高于生存组,差异有统计学意义(P<0.05);血清sTREM-1、NF-κB对脓毒症ALI患者疾病预测曲线下面积(AUC)值、特异值和灵敏值分别为0.861、85.57%、78.26%和0.797、74.23%、73.91%.结论sTREM-1和NF-κB可以作为脓毒症急性肺损伤患者疾病进展和预后的重要生物标志物,通过检测sTREM-1和NF-κ B水平,可以早期发现疾病进展,为临床治疗提供依据.
Objective:To explore and analyze the evaluation value of soluble Triggering Receptor Expressed on Myeloid cells-1(sTREM-1)and nuclear transcription factor-κ B(NF-κ B)in the disease progression and prognosis of patients with acute lung injury(ALI)caused by sepsis.Method:A total of 120 patients with ALI due to sepsis who were diagnosed and admitted to Nanxishan Hospital in Guangxi Zhuang Autonomous Region between March 2022 and March 2024.According to disease severity,they were stratified into a mild group(n=58),a moderate group(n=37),and a severe group(n=25).Levels of sTREM-1 and NF-κB,Sequential Organ Failure Assessment(SOFA)scores,and Acute Physiology and Chronic Health Evaluation Ⅱ(APACHE Ⅱ)scores were compared among the patients.The Pearson method was used to analyze the correlations between serum sTREM-1,NF-κB and SOFA and APACHE Ⅱ scores.A 28-day follow-up was conducted to record survival outcomes.Receiver operating characteristic(ROC)curve analysis was performed to evaluate the predictive value of serum sTREM-1 and NF-κB levels for sepsis-induced ALI.Result:In patients with sepsis-induced ALI,serum levels of sTREM-1 and NF-κB,as well as SOFA and APACHE Ⅱ scores,showed a graded increase across severity groups:severe group>moderate group>mild group,with statistically significant differences(P<0.05).The levels of serum sTREM-1 and NF-κB in patients with sepsis ALI were significantly positively correlated with the SOFA and APACHEII scores,and the difference was statistically significant(P<0.05).Furthermore,serum sTREM-1 and NF-κB levels were significantly higher in the non-survivor group compared to the survivor group(P<0.05).The area under the disease prediction curve(AUC)values,specific values and sensitive values of serum sTREM-1 and NF-κB for patients with sepsis and ALI were 0.861,85.57%,78.26%and 0.797,74.23%,73.91%,respectively.Conclusion:sTREM-1 and NF-κB can serve as important biomarkers for disease progression and prognosis in patients with acute lung injury caused by sepsis.By detecting the levels of sTREM-1 and NF-κB,disease progression can be detected at an early stage,providing a basis for clinical treatment.
孙婧;邓秋芳;甘金城;姚玉玲;张黎
广西壮族自治区南溪山医院(广西壮族自治区第二人民医院) 广西 桂林 541002广西壮族自治区南溪山医院(广西壮族自治区第二人民医院) 广西 桂林 541002广西壮族自治区南溪山医院(广西壮族自治区第二人民医院) 广西 桂林 541002广西壮族自治区南溪山医院(广西壮族自治区第二人民医院) 广西 桂林 541002广西壮族自治区南溪山医院(广西壮族自治区第二人民医院) 广西 桂林 541002
血清sTREM-1NF-κB脓毒症急性肺损伤疾病进展预后
Soluble Triggering Receptor Expressed on Myeloid cells-1Nuclear transcription factor-κBSepsisAcute lung injuryDisease progression prognosis
《中外医学研究》 2026 (5)
13-16,4
广西壮族自治区卫生健康委员会自筹经费科研课题(Z20212237)
评论